Items filtered by date: February 2017

“Using a regression model and data from the US National Youth Tobacco Surveys from 1999-2013, researchers estimated that the 2009 ban on flavored cigarettes reduced the probability of becoming a smoker among youth by 17% and reduced the number of cigarettes smoked by youth smokers by 58%. However, the ban was associated with a 45% increase in youth use of menthol-flavored cigarettes,

The Cost of Illness approach was used to estimate the economic cost of smoking attributable-diseases in 2012 in 152 countries, representing 97% of the world's smokers. “The amount of healthcare expenditure due to smoking-attributable diseases totaled purchasing power parity (PPP) $467 billion (US$422 billion) in 2012, or 5.7% of global health expenditure. The total economic cost of smoking (from health expenditures and productivity losses together) totaled PPP $1852 billion (US$1436 billion) in 2012, equivalent in magnitude to 1.8%

US adult current tobacco use is still more than a quarter (27.6%) for adults using at least one type of tobacco product in 2013 and 2014, although the prevalence varied depending on use category. “A total of 8.9% of youths had used a tobacco product in the previous 30 days; 1.6% of youths were daily users. Approximately 40% of tobacco users, adults and youths alike, used multiple tobacco products; cigarettes plus e-cigarettes was the most common combination.”

Using modeling of US data, this study explores the relative risks of vaping versus smoking during pregnancy. It suggests that there is high unmet demand among young pregnant women for smoking cessation products, which is why many turn to vaping. “Pregnancy may provide a unique window when women are open to guidance about resources and products available to help them to quit smoking. In the absence of such guidance, pregnant women may be more likely to use ENDS. Tobacco cessation pharmacotherapy